Literature DB >> 23715910

Patients' expectations of deep brain stimulation, and subjective perceived outcome related to clinical measures in Parkinson's disease: a mixed-method approach.

Franziska Maier1, Catharine J Lewis, Nina Horstkoetter, Carsten Eggers, Elke Kalbe, Mohammad Maarouf, Jens Kuhn, Mateusz Zurowski, Elena Moro, Christiane Woopen, Lars Timmermann.   

Abstract

OBJECTIVE: To study patients' expectations of subthalamic deep brain stimulation (STN-DBS) and their subjective perceived outcome, by using qualitative and quantitative methods in Parkinson's disease (PD).
METHODS: PD patients were prospectively examined before and 3 months after surgery. Semistructured interviews regarding preoperative expectations and postsurgical subjective perceived outcome were conducted. These were analysed using content analysis. For statistical analyses, patients were classified according to their subjective perceived outcome, resulting in three different subjective outcome groups (negative, mixed, positive outcome). The groups were used for multiple comparisons between and within each group regarding motor impairment, quality of life (QoL), neuropsychiatric status and cognitive functioning, using standard instruments. A logistic regression analysis was conducted to find predictors of subjective negative outcome. Receiver operating characteristic curves were used to analyse cut-off scores for predictive tests.
RESULTS: Of the 30 PD patients participating, 8 had a subjective negative outcome, 8 a mixed and 14 a positive outcome. All groups significantly improved in motor functioning. Patients with subjective negative outcome were characterised by preoperative unrealistic expectations, no postsurgical improvement in QoL, and significantly higher presurgical and postsurgical apathy and depression scores. Higher preoperative apathy and depression scores were significant predictors of negative subjective outcome. Cut-off scores for apathy and depression were identified.
CONCLUSIONS: The mixed-method approach proved useful in examining a patient's subjective perception of STN-DBS outcome. Our results show that significant motor improvement does not necessarily lead to a positive subjective outcome. Moreover, PD patients should be screened carefully before surgery regarding apathy and depression. (DRKS-ID: DRKS00003221).

Entities:  

Keywords:  NEUROPSYCHIATRY; NEUROPSYCHOLOGY; PARKINSON'S DISEASE; QUALITY OF LIFE; STEREOTAXIC SURGERY

Mesh:

Substances:

Year:  2013        PMID: 23715910     DOI: 10.1136/jnnp-2012-303670

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  28 in total

1.  Deep brain stimulation and cognitive decline in Parkinson's disease: The predictive value of electroencephalography.

Authors:  A Markser; Franziska Maier; C J Lewis; T A Dembek; D Pedrosa; C Eggers; L Timmermann; E Kalbe; G R Fink; Lothar Burghaus
Journal:  J Neurol       Date:  2015-07-11       Impact factor: 4.849

2.  Long-term Parkinson's disease quality of life after staged DBS: STN vs GPi and first vs second lead.

Authors:  Stephanie Cernera; Robert S Eisinger; Joshua K Wong; Kwo Wei David Ho; Janine Lobo Lopes; Kevin To; Samuel Carbunaru; Adolfo Ramirez-Zamora; Leonardo Almeida; Kelly D Foote; Michael S Okun; Aysegul Gunduz
Journal:  NPJ Parkinsons Dis       Date:  2020-07-06

3.  Deep brain stimulation of the nucleus basalis of Meynert in Alzheimer's dementia.

Authors:  J Kuhn; K Hardenacke; D Lenartz; T Gruendler; M Ullsperger; C Bartsch; J K Mai; K Zilles; A Bauer; A Matusch; R-J Schulz; M Noreik; C P Bührle; D Maintz; C Woopen; P Häussermann; M Hellmich; J Klosterkötter; J Wiltfang; M Maarouf; H-J Freund; V Sturm
Journal:  Mol Psychiatry       Date:  2014-05-06       Impact factor: 15.992

4.  The impact of subthalamic deep brain stimulation on caregivers of Parkinson's disease patients: an exploratory study.

Authors:  Catharine J Lewis; Franziska Maier; Nina Horstkötter; Carsten Eggers; Veerle Visser-Vandewalle; Elena Moro; Mateusz Zurowski; Jens Kuhn; Christiane Woopen; Lars Timmermann
Journal:  J Neurol       Date:  2014-11-09       Impact factor: 4.849

5.  Insights gleaned by measuring patients' stated goals for DBS: More than tremor.

Authors:  Cynthia S Kubu; Scott E Cooper; Andre Machado; Thomas Frazier; Jerrold Vitek; Paul J Ford
Journal:  Neurology       Date:  2016-12-02       Impact factor: 9.910

6.  DBS-Edmonton App, a Tool to Manage Patient Expectations of DBS in Parkinson Disease.

Authors:  Kevin Yen; Janis M Miyasaki; Michelle Waldron; Lin Yu; Tejas Sankar; Fang Ba
Journal:  Neurol Clin Pract       Date:  2021-06

Review 7.  Functional Movement Disorders and Placebo: A Brief Review of the Placebo Effect in Movement Disorders and Ethical Considerations for Placebo Therapy.

Authors:  Bonnie M Kaas; Casey Jo Humbyrd; Alexander Pantelyat
Journal:  Mov Disord Clin Pract       Date:  2018-10-09

Review 8.  Challenges in PD Patient Management After DBS: A Pragmatic Review.

Authors:  Malco Rossi; Verónica Bruno; Julieta Arena; Ángel Cammarota; Marcelo Merello
Journal:  Mov Disord Clin Pract       Date:  2018-02-28

Review 9.  Clinical Ethics in the Context of Deep Brain Stimulation for Movement Disorders.

Authors:  Cynthia S Kubu; Paul J Ford
Journal:  Arch Clin Neuropsychol       Date:  2017-11-01       Impact factor: 2.813

10.  Patient-Centered Identification of Meaningful Regulatory Endpoints for Medical Devices to Treat Parkinson's Disease.

Authors:  Heather L Benz; Brittany Caldwell; John P Ruiz; Anindita Saha; Martin Ho; Stephanie Christopher; Dawn Bardot; Margaret Sheehan; Anne Donnelly; Lauren McLaughlin; Brennan Mange; A Brett Hauber; Katrina Gwinn; William J Heetderks; Murray Sheldon
Journal:  MDM Policy Pract       Date:  2021-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.